Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRKCQ | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | SRPX | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | CHST2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | TLR7 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | ARHGAP11A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | GREM2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | RNF121 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | C14orf1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | UGT3A2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | MFSD9 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |